Clinical Trials Logo

Citation(s)

  •   Beletsky L, Ruthazer R, Macalino GE, Rich JD, Tan L, Burris S
    Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities. J Urban Health. 2007 Jan;84(1):126-36.
  •   Clark AK, Wilder CM, Winstanley EL
    A systematic review of community opioid overdose prevention and naloxone distribution programs. J Addict Med. 2014 May-Jun;8(3):153-63. doi: 10.1097/ADM.0000000000000034. Review.
  •   Coffin PO, Fuller C, Vadnai L, Blaney S, Galea S, Vlahov D
    Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City. J Urban Health. 2003 Jun;80(2):288-90.
  •   Doyon S, Aks SE, Schaeffer S
    Expanding access to naloxone in the United States. J Med Toxicol. 2014 Dec;10(4):431-4. doi: 10.1007/s13181-014-0432-1.
  •   Meyers K, Webb A, Frantz J, Randall M
    What does it take to retain substance-abusing adolescents in research protocols? Delineation of effort required, strategies undertaken, costs incurred, and 6-month post-treatment differences by retention difficulty. Drug Alcohol Depend. 2003 Jan 24;69(1):73-85.
  •   United Nations Office on Drugs and Crime, World Health Organization
    Discussion paper UNODC/WHO 2013: Opioid overdose: preventing and reducing opioid overdose mortality. 2013; Available at: http://www.unodc.org/docs/treatment/overdose.pdf. Accessed 04/23, 2014. Archived by WebCite© at http://www.webcitation.org/6U3qbjl2E)

Protocol for a Mixed Methods Feasibility Study for the Surviving Opioid Overdose With Naloxone Education and Resuscitation (SOONER) Trial

Details for clinical trial NCT03821649